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Human myeloperoxidase (MPO) uses hydrogen peroxide generated by the oxidative burst of neutrophils
to produce an array of antimicrobial oxidants. During this process MPO is irreversibly inactivated. This
study focused on the unknown role of hydrogen peroxide in this process. When treated with low concen-
trations of H2O2 in the absence of reducing substrates, there was a rapid loss of up to 35% of its peroxidase
activity. Inactivation is proposed to occur via oxidation reactions of Compound I with the prosthetic
group or amino acid residues. At higher concentrations hydrogen peroxide acts as a suicide substrate
with a rate constant of inactivation of 3.9  103 s1. Treatment of MPO with high H2O2 concentrations
resulted in complete inactivation, Compound III formation, destruction of the heme groups, release of
their iron, and detachment of the small polypeptide chain of MPO. Ten of the protein’s methionine res-
idues were oxidized and the thermal stability of the protein decreased. Inactivation by high concentra-
tions of H2O2 is proposed to occur via the generation of reactive oxidants when H2O2 reacts with
Compound III. These mechanisms of inactivation may occur inside neutrophil phagosomes when reduc-
ing substrates for MPO become limiting and could be exploited when designing pharmacological
inhibitors.
 2013 The Authors. Published by Elsevier Inc. Open access under CC BY-NC-ND license.Introduction
Neutrophils are the predominant white blood cells in circula-
tion. They are highly specialized for their primary function, the
phagocytosis and destruction of invading pathogens by antimicro-
bial proteins and reactive oxidants [1]. When stimulated, neutro-
phils consume oxygen in a respiratory burst that produces
superoxide and hydrogen peroxide [1]. Simultaneously, these
white blood cells discharge the abundant heme enzyme myeloper-
oxidase (MPO)1 that uses hydrogen peroxide to oxidize chloride,
bromide and thiocyanate to the respective hypohalous acids andhypothiocyanite. These oxidants kill ingested bacteria but are also
implicated in tissue damage associated with numerous inﬂamma-
tory diseases [2]. It has been demonstrated that during phagocytosis
the amount of extractable neutrophilic MPO decreases while a sig-
niﬁcant fraction of the soluble enzyme is inactivated [3,4]. The
mechanism by which this occurs and its relevance to infection and
inﬂammation have yet to be investigated in detail.
Enzyme inactivation is likely to involve reactions with either
hydrogen peroxide or its products because they have the poten-
tial to oxidatively modify amino acids and the prosthetic heme
group. It has been demonstrated with several heme peroxidases,
including horseradish peroxidase [5,6], ascorbate peroxidase [7]
and lactoperoxidase [8], that hydrogen peroxide alone can pro-
mote irreversible inactivation. There are also reports that MPO
is inactivated by hydrogen peroxide in the absence of exogenous
electron donors [9,10]. However, the mechanism of inactivation
and the effect on its structural integrity have not been
investigated.
In this study we aimed to show how hydrogen peroxide affects
the activity of MPO and describe the mechanisms involved in en-
zyme inactivation. We demonstrate that MPO is highly sensitive
to inactivation by hydrogen peroxide. Irreversible inactivation of
MPO was accompanied by changes in its secondary and tertiary
architecture including breakage of covalent heme linkages and dis-
ruption of its subunit structure.
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Reagents
HumanMPO(lyophilizedandhighlypuriﬁed, Reinheitszahl 0.84)
was obtained from Planta Natural Products (http://www.planta.at)
and the concentrationwas determined spectrophotometricallywith
a molar extinction coefﬁcient of 91,000 M1 cm1 per heme [11].
Hydrogen peroxide (30% analytical grade) was purchased from Bio-
lab (Aust) Ltd. and concentrations were determined spectrophoto-
metrically using a molar extinction coefﬁcient of 43.6 M1 cm1 at
240 nm [12]. TMB (3,30,5,50-tetramethylbenzidine), xylenol orange,
D-sorbitol, diethylenetriaminepentaacetic acid (DTPA), alkyltri-
methylammonium bromide (cetrimide), glucose, catalase from
bovine liver, bovine superoxide dismutase, glucose oxidase from
Aspergillus niger, 3-(2-pyridyl)-5,6-diphenyl-1,2,4-triazine-p,
p0-disulfonic acid monosodium salt hydrate (ferrozine) and L-ascor-
bate were purchased from Sigma. Dimethylformamide and ferrous
ammonium sulfate were from J.T. Baker.
All spectrophotometric assays were performed on an Agilent
8453 diode array spectrophotometer. For enhanced chemilumines-
cence Amersham™ ECL Plus Western Blotting Detection System
from GE Healthcare was used.Myeloperoxidase activity assays
The residual peroxidase activity of MPO was determined by
measuring its ability to oxidize TMB. MPO (32 nM) in 50 mM so-
dium phosphate buffer, pH 7.4, and 100 lM DTPA was incubated
at various protein to hydrogen peroxide ratios and aliquots were
taken over time to assess the decline in peroxidase activity. Super-
oxide dismutase was added to a separate number of experiments
at a concentration of 20 lg/mL to investigate the requirement for
superoxide in enzyme inactivation caused by hydrogen peroxide.
Residual peroxidase activity was measured by adding a 25 lL ali-
quot to 850 lL of 200 mM sodium acetate buffer, pH 5.4, contain-
ing 0.01% cetrimide, 100 lL of 20 mM TMB in DMF (made fresh
each day and kept in the dark) and 25 lL of 8 mM hydrogen perox-
ide. Reactions were performed at 28 ± 0.5 C and started by addi-
tion of the MPO aliquot. TMB oxidation was followed at 670 nm
and initial rates were calculated over the ﬁrst 60 s of the
reaction.
The halogenation activity of MPO was determined under the
same conditions as described above with the exception that
10 mM bromide was present in the TMB assay. Under these condi-
tions, bromide was the preferred substrate for MPO and was con-
verted to HOBr, which was responsible for 80% of the oxidation
of TMB with the remainder due to direct oxidation by MPO (i.e.,
peroxidase activity).Determination and generation of hydrogen peroxide
Consumption of hydrogen peroxide by MPO was measured
using ferrous iron-catalyzed oxidation of xylenol orange (FOX as-
say) [13]. The FOX reagent was composed of 1 mM ammonium fer-
rous sulfate, 400 lM xylenol orange and 400 mM D-sorbitol in
200 mM H2SO4. Each peroxide assay was performed by adding
70 lL of sample to 25 lL FOX reagent while vortexing. The solution
was then incubated at room temperature for 45 min in the dark
prior to reading the absorbance at 560 nm. The hydrogen peroxide
concentration was calculated against a standard curve of the range
of 0–5 nM hydrogen peroxide. Samples with concentrations higher
than the standard curve range were diluted accordingly in 50 mM
phosphate buffer, pH 7.4, before adding to the FOX reagent. This
assay was also used to determine the rate at which glucose oxidaseand glucose (1 mg/mL) produced hydrogen peroxide in 50 mM
phosphate buffer, pH 7.4. The ﬂux of hydrogen peroxide was linear
over 60 min and increasing concentrations of glucose oxidase (0.1–
2.5 lg/mL glucose oxidase) gave a linear increase in production of
hydrogen peroxide (9.4 lM–285.5 lM per h).Spectral analysis of myeloperoxidase
Spectra of 1.5 lMMPO in 50 mM phosphate buffer, pH 7.4, con-
taining 100 lM DTPA were recorded after reactions were started
by adding hydrogen peroxide. To determine how peroxidase or
halogenation substrates inﬂuenced the degradation of the heme
groups of MPO, 200 lM ascorbate or 5 mM bromide with 5 mM
methionine, respectively were also added as indicated below. The
involvement of superoxide was checked by adding 20 lg/mL SOD
to a separate set of reactions.SDS–PAGE analyses
To follow the impact of hydrogen peroxide on the structural
integrity of myeloperoxidase, 1.5 lMMPO in 50 mM sodium phos-
phate buffer, pH 7.4, and 100 lMDTPAwas incubated with 1.5 mM
hydrogen peroxide. Aliquots were taken at 5, 10, 25, 40 and 60 min
and residual hydrogen peroxide was removed by adding 20 lg/mL
catalase. Samples of 15 lL were added to non-reducing and reduc-
ing sample loading buffers, respectively (ﬁnal concentrations: 2%
SDS, 10% glycerol, 125 mM Tris–HCl buffer, pH 6.5, and for
reducing SDS–PAGE 1% b-mercaptoethanol). Samples were loaded
without prior heating and resolved by 8–20% gradient SDS–
polyacrylamide gel electrophoresis. Gels were stained with
Coomassie Brilliant Blue R-250 for 60 min and subsequently
destained. Gels were scanned using ChemiDoc XRS (Bio-Rad).
Furthermore, 1.5 lM MPO in 50 mM sodium phosphate buffer,
pH 7.4, and 100 lMDTPA was incubated with the following hydro-
gen peroxide: protein ratios: 1:1, 5:1, 10:1, 40:1, 100:1, 167:1,
500:1, 1000:1 and 2000:1 for 2 h at room temperature. Samples
were resolved on SDS–PAGE, stained and analyzed as described
above.
For detection of intact heme covalently linked to the protein,
MPO was incubated with hydrogen peroxide and resolved by
SDS–PAGE under the same conditions as described above and sub-
sequently blotted onto a PVDF membrane (100 V, 60 min). En-
hanced chemiluminescence (Amersham™ ECL Plus Western
Blotting Detection System, GE Healthcare) was used to detect cova-
lently bound and intact heme [14].Analysis of free iron
Release of free iron from the heme prosthetic group of MPO was
measured colorimetrically using ferrozine following a published
method but with slight modiﬁcations [15]. After buffer exchange
with 50 mM sodium acetate buffer, pH 7.4, using a Micro Bio-Spin
chromatography column (Bio-Rad) 1.5 lM MPO was treated with
1.5 mM hydrogen peroxide and incubated at room temperature
for 2 h. The volume of 1 mL was reduced to dryness and the pellet
resuspended in 30 lL water. Ascorbic acid (30 lL of 1.13 mM in
0.2 M HCl) was added and left for 5 min. The protein was then pre-
cipitated by adding 30 lL of 11.3% trichloroacetic acid and samples
were kept on ice for 5 min followed by a short fast spin at 4 C. Fi-
nally, 36 lL of 10% ammonium acetate was added to the superna-
tant followed by 9 lL of 6.1 mM ferrozine and the absorbance at
563 nm was measured after 5 min (e = 28,000 M1 cm1).
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Differential calorimetric (DSC) measurements were performed
using a VP-capillary DSC microcalorimeter from Microcal (cell vol-
ume: 137 lL), controlled by the VP-viewer program and equipped
with an autosampler for 96 well plates. Samples were analyzed
using a programmed heating scan rate of 60 C h1 over a temper-
ature range of 20–110 C and a cell pressure of approximately 60
psi (4.136 bar). The maximum temperature inside the cuvette
was 95 C. Collected DSC data were corrected for buffer baseline
and normalized for protein concentration. The reaction conditions
were: 5 lMMPO in 5 mM phosphate buffer, pH 7, in the absence or
presence of 500 lM or 5 mM hydrogen peroxide for 60 min). Guan-
idinium hydrochloride (GdnHCl; 5 mM) was added before mea-
surements were started to avoid non-speciﬁc protein aggregation
at increasing temperatures.
Microcal origin software was used for data analysis. Heat capac-
ity (Cp) was expressed in kcal mol1 K1 (1 cal = 4.184 J). Data
points were ﬁtted to non-two-state equilibrium-unfolding models
by the Lavenberg/Marquardt (LM) non-linear least square method.
Electronic circular dichroism spectrometry
Thermal unfolding was also followed by electronic circular
dichroism (ECD) spectroscopy (Chirascan, Applied Photophysics,
Leatherhead, UK). The instrument was ﬂushed with nitrogen at a
ﬂow rate of 5 L min1 and was capable of simultaneous UV–vis
and ECD monitoring. The instrument was equipped with a Peltier
element for temperature control and temperature-mediated dena-
turation was monitored between 20 and 95 C with stepwise incre-
ments of 1.0 C min1.
Single wavelength scans were performed with instrumental
parameters set as follows. Visible ECD at a Soret minimum of
412 nm was performed with 5 lMMPO in 5 mM phosphate buffer,
pH 7.0, containing 0.5 M GdnHCl to avoid aggregation at higher
temperatures. Samples were monitored in the absence and pres-
ence of 100 and 1000-fold excesses of hydrogen peroxide over
60 min. The pathlength was 10 mm, spectral bandwidth 1 nm
and the scan time per point was set at 10 s. Far-UV ECD at
222 nm was performed on the same samples with the pathlength
set at 1 mm, spectral bandwidth at 3 nm and the scan time per
point was set at 10 s.
The fraction a of unfolded protein was calculated according to
a = (hN  h)/(hN  hU) with hN being the ellipticity (in mdeg) at
222 nm of the protein in the native folded state, h the ellipticity
at deﬁned temperature (T), and hU being the ellipticity at 222 nm
of the completely unfolded state.
Mass spectrometric analyses
To determine which amino acid residues become oxidized dur-
ing enzyme inactivation, 1.5 lM MPO was incubated with 1.5 mM
hydrogen peroxide in 50 mM sodium phosphate buffer, pH 7.4. The
treated sample and a control sample were reduced and alkylated
prior to trypsin digestion following standard procedures. Changes
in the tryptic peptides due to oxidation were then determined by
LC-MS/MS at the center for Protein Research, University of Otago,
Dunedin. Each sample was analyzed four times using the same
instrument settings.
For LC-MS/MS analysis of tryptic peptides samples were recon-
stituted in 5% (v/v) acetonitrile, 0.2% (v/v) formic acid in water and
injected onto an Ultimate 3000 nano-ﬂow HPLC-System (Thermo
Scientiﬁc, Dionex Co, CA) that was in-line coupled to the nanospray
source of a LTQ Orbitrap XL hybrid mass spectrometer (Thermo
Scientiﬁc, San Jose, CA). Peptides were loaded onto a PepMap100
trap column (Thermo Scientiﬁc, Dionex Co, CA) and separated ona PepMapRSLC analytical column (75 lm  150 mm; Thermo Sci-
entiﬁc, Dionex Co, CA) by a gradient developed from 5% (v/v) ace-
tonitrile, 0.2% (v/v) formic acid to 80% (v/v) acetonitrile, 0.2% (v/v)
formic acid in water at a ﬂow rate of 400 nL/min.
Full MS in the mass range between m/z 400 and 2000 was per-
formed in the Orbitrap mass analyzer with a resolution of 60,000 at
m/z 400 and an AGC target of 5e5. Preview mode for FTMS master
scan was enabled to generate precursor mass lists. The strongest
ﬁve signals were selected for collision induced dissociation (CID)-
MS/MS in the LTQ ion trap at a normalized collision energy of
35% using an AGC target of 2e4 and one microscan. Dynamic exclu-
sion was enabled with one repeat counts during 60 s and an exclu-
sion period of 180 s. Exclusion mass width was set to 0.01.
For protein identiﬁcation MS/MS data were searched against a
user deﬁned amino acid sequence database containing the target
sequence using the SEQUEST program operated through the Prote-
ome Discoverer software (Thermo Scientiﬁc). The search was set
up for full tryptic peptides with a maximum of two missed cleav-
age sites. Carboxyamidomethyl cysteine, oxidation (Cys, Met),
dioxidation (Cys, Met), trioxidation (Cys) were selected as variable
modiﬁcations. The precursor mass tolerance threshold was 10 ppm
and the maximum fragment mass error 0.8 Da. Ion chromatograms
were compared pair-wise using the SIEVE software (Thermo Scien-
tiﬁc). The SIEVE Frame List was ﬁltered for monoisotopic peaks and
positive identiﬁcations (based on the imported SEQUEST search re-
sults). For the analysis of differential modiﬁcations the SIEVE
Frame List and the Proteome Discoverer Peptide List were both
integrated into a relational database (Microsoft Access) and linked
by the unique combination of scan number and raw ﬁle name.Results
Kinetics of inactivation of MPO by hydrogen peroxide
Myeloperoxidase was incubated with a given concentration of
hydrogen peroxide in the absence of reducing substrate. Then, ali-
quots were taken and the residual enzyme activity was deter-
mined. As there were no differences between the residual
halogenation and peroxidase activity, only the latter activity was
measured in further experiments. The enzyme was incubated with
increasing stoichiometric excesses of hydrogen peroxide and the
loss of peroxidase activity was determined over time. These exper-
iments were carried out in the absence of reducing substrates. At
low ratios of hydrogen peroxide to MPO (65:1), there was rapid
but limited inactivation (Fig. 1A). For example, at ratio of 5:1,
approximately 30% of the enzyme’s activity was lost within
10 min. No further loss in activity occurred after this time. Interest-
ingly, the rate of inactivation decreased as the ratio of hydrogen
peroxide to MPO was increased to 20:1 and then 1000:1 (Fig. 1A
and B). Thereafter the rate of inactivation increased with increasing
molar ratios of hydrogen peroxide to MPO (Fig. 1B).
When the ratio of hydrogen peroxide to MPO was kept constant
at 5000:1 but the concentrations varied, it was evident that the
rate of inactivation was dependent on the concentration of hydro-
gen peroxide (Fig. 1C). As an alternative to this experiment, we also
generated a slow ﬂux of hydrogen peroxide with glucose oxidase to
maintain a low steady-state concentration of hydrogen peroxide
but still expose the enzyme to similar doses of hydrogen peroxide
as when we used bolus additions of the substrate. The rate of inac-
tivation of MPO over the ﬁrst 25 min of reaction was independent
of the ﬂux of hydrogen peroxide (Fig. 1D). The extent of inactiva-
tion, however, increased with increasing ﬂuxes of hydrogen perox-
ide. Interestingly, at the lowest ﬂux of hydrogen peroxide (i.e.,
0.5 lM/min) inactivation reached a maximum of only about 40%
which is similar to that obtained with a bolus addition of 160 nM
Fig. 1. Loss of peroxidatic activity of myeloperoxidase upon incubation with hydrogen peroxide. (A) Loss of peroxidase activity at low MPO to hydrogen peroxide ratios.
32 nM MPO reacted with hydrogen peroxide at oxidant to protein ratios of (d) 1:1, (s) 5:1 and (.) 20:1 in 50 mM phosphate buffer, pH 7.4, containing 100 lM DTPA. The
residual peroxidase activity of MPO was determined by taking aliquots over time and measuring the TMB peroxidase activity (n = 2). (B) 32 nM MPO was incubated with
hydrogen peroxide at H2O2 to protein ratios of (d) 1000:1 (32 lM H2O2), (s) 5000:1 (160 lM H2O2), (.) 10,000:1 (320 lM H2O2), in 50 mM phosphate buffer, pH 7.4, with
100 lMDTPA. Aliquots were taken and the residual TMB activitiy of MPO over time was determined (n = 3). (C) Loss of peroxidase activity at a constant hydrogen peroxide to
protein ratio. MPO was incubated with a 5000-fold stoichiometric excess of hydrogen peroxide at varying enzyme concentrations: (d) 160 lM, (s) 240 lM, (.) 320 lM, (D)
640 lM and (j) 1280 lM H2O2 in 50 mM phosphate buffer, pH 7.4, with 100 lM DTPA. MPO concentrations ranged accordingly from 32 to 256 nM. Residual TMB activities
over time are presented (n = 3). (D) Loss of peroxidase activity when MPO was reacted with a steady ﬂux of hydrogen peroxide. 32 nM MPO reacted with a continuous
hydrogen peroxide ﬂux of (d) 33.3 lM/60 min, (s) 153.3 lM/60 min and (.) 286.6 lM/60 min hydrogen peroxide in 50 mM phosphate buffer, pH 7.4, and 100 lM DTPA.
Residual activity over time was determined by the TMB peroxidase activity assay (n = 2).
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susceptible to low concentrations of hydrogen peroxide. Higher
concentrations of hydrogen peroxide protect the enzyme from a
fast inactivation event but at the highest concentrations a slower
inactivation process occurs that is dependent on the concentration
of hydrogen peroxide.
Next we determined whether the kinetics of inactivation at high
concentrations of hydrogen peroxide conform to the equations
developed for mechanism-based inhibitors [16]. Plotting the initial
concentration of MPO against the concentration of hydrogen per-
oxide consumed over 60 min gave a straight line with the slope
representing the partition ratio (r) for turnover versus inactivation
(Fig. 2A). The value obtained indicates that the enzyme turned over
799 times before it was fully inactivated. However, as will be out-
lined below (see also Fig. 7), each mole of MPO consumes two mo-
les of H2O2, if it follows the peroxidase cycle (r = 400), and three
moles of H2O2 are consumed if Compound III is involved in turn-
over (r = 266).
Half-times for inactivation were determined from the data in
Fig. 1C and plotted according to Equation (1). From the slope of the
secondary plot depicted in Fig. 2B the rate constant for inactivation
(kin)wasdetermined tobe3.9  103 s1while thedissociation con-
stant for hydrogenperoxide (K0)was calculated from the intercept to
be 740 lM. It is evident from this analysis that inactivation of MPO
conforms to the model proposed for mechanism-based inactivation[15] and hydrogen peroxide can be considered to be a suicide sub-
strate for MPO.
H2O2½ 0  t1=2 ¼ lnð2-MÞ=ð1-MÞ½   ðK0=kinÞ þ ðln2=kinÞ
 H2O2½ 0 ð1Þ
where M = (1 + r)  [MPO]o / [H2O2]o
Spectral analysis of MPO reacting with hydrogen peroxide
MPO has numerous redox intermediates that have distinct
absorption spectra [17]. To demonstrate which of these redox
intermediates are involved in the turnover and inactivation of
the enzyme, absorption spectra were recorded at different molar
ratios of hydrogen peroxide to MPO. In these analyses the redox
intermediates Compound II and Compound III were distinguished
from each other by the ratio of absorbances at 625 and 456 nm
(A625/A456), which are 0.17 for Compound II and 0.54 for Compound
III [17]. When 1.5 lM MPO was reacted with 60 lM of hydrogen
peroxide, A625/A456 changed to 0.20 within 5 s, which indicates that
the enzyme was almost completely converted to Compound II
(Fig. 3A). Compound II subsequently slowly decayed back to the
ferric MPO and no more spectral changes could be observed after
120 min. At this time the Soret absorbance at 430 nm was
decreased by 6.2 ± 2.8%. Under these conditions all the hydrogen
Fig. 2. Mechanistic analysis of inactivation of myeloperoxidase by hydrogen
peroxide. (A) Partition ratio for the inactivation of MPO by hydrogen peroxide.
Residual hydrogen peroxide concentrations were measured at 60 min using the FOX
assay when MPO reacted with increasing hydrogen peroxide concentrations at the
constant hydrogen peroxide to protein ratio of 5000:1 in 50 mM phosphate buffer,
pH 7.4, and 100 lM DTPA (same conditions as Fig. 1C). (B) Determination of kinetic
parameters for the inactivation of MPO by H2O2. Half-times of inactivation, t1/2,
were determined from Fig. 1C and initial concentrations of hydrogen peroxide were
used in the secondary plot.
Fig. 3. Spectral analysis of MPO reacting with hydrogen peroxide. 1.5 lMMPO was
incubated with 60 lM H2O2 (A), 250 lM H2O2 (B) and 1.5 mM H2O2 (C) in 50 mM
phosphate buffer, pH 7.4, 100 lM DTPA. Time resolved spectra were recorded over
time. The black spectrum depicts the spectral signature of ferric MPO before
addition of H2O2, arrows indicate direction of spectral changes. Insets represent
consumption of hydrogen peroxide over time as measured by the FOX assay as well
as the residual peroxidase activity determined with the TMB-assay.
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activity (insets to Fig. 3A). At 250 lM hydrogen peroxide, MPO
was also rapidly converted to Compound II but there was a greater
loss of the absorbance at 430 nm (19.9 ± 3.2%) (Fig. 3B). Under
these conditions all the hydrogen peroxide was consumed within
ﬁve minutes and the enzyme lost about 30% of its activity (insets
to Fig. 3B). With 1.5 mM of hydrogen peroxide, the enzyme was
converted to a mixture of about 50% Compound II and 50% Com-
pound III (A625/A456 = 0.33), with a subsequent fast decrease in
absorbance at 454 nm. At 60 min the loss of absorbance at
430 nmwas 78.1 ± 1.3% after which no more spectral changes were
observed (Fig. 3C). Under these conditions MPO consumed all
hydrogen peroxide and lost most of its activity within 20 min (in-
sets to Fig. 3C).
With all concentrations of hydrogen peroxide, adding 100 lM
ascorbate at the end of the reactions did not restore the absorbance
at 430 nm. Consequently, because ascorbate readily reduces Com-
pounds I and Compound II [18], it is apparent that the loss of heme
absorbance was due to an irreversible oxidative modiﬁcation and
not incomplete conversion of the redox intermediates back to the
native MPO.
From these results we conclude that MPO readily consumes
hydrogen peroxide in the absence of other reducing substrates.
During this process heme absorbance is lost and enzyme activity
declines. As the enzyme consumed more hydrogen peroxide, there
was greater heme destruction and enzyme inactivation, which was
associated with conversion of the enzyme to Compound III.Protective effect of reducing substrates on loss of heme absorbance
To determine whether reducing substrates protect the enzyme
against inactivation by hydrogen peroxide, absorption spectra
were recorded under the same conditions as in Fig. 3A–C but in
the presence of either ascorbate or bromide plus methionine.
Ascorbate is a classical peroxidase substrate that reduces Com-
pound I and Compound II [18] with a single electron whereas bro-
mide is a halogenation substrate that donates two electrons to
Compound I and is oxidized to hypobromous acid [17]. Methionine
was present in this reaction to scavenge produced HOBr. Addition
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absorbance at 430 nm at all concentrations of hydrogen peroxide
(Table 1). Compound II was formed in the presence of ascorbate
and all the hydrogen peroxide was consumed within a few min-
utes. Bromide also protected the enzyme but was less effective
than ascorbate. In its presence, conversion of Compound II back
to native MPO took much longer than with ascorbate (Table 1).
Hydrogen peroxide-mediated changes to the structure of MPO
Treatment of 1.5 lM MPO with 1.5 mM of hydrogen peroxide
resulted in the release of approximately 85% of the iron from the
protein (Fig. 4A). This result correlated very well with the loss of
heme absorbance observed under the same conditions (Fig. 3C)
and suggests that the oxidative break down of the heme prosthetic
group causes it to release the chelated iron.
The effect of hydrogen peroxide on the overall structure of MPO
was analyzed by gel electrophoresis. Chemiluminescence [14] was
used to detect changes in the heme content of the protein. Hydro-
gen peroxide was added to MPO at a 1000:1 ratio and aliquots
were taken over time after the reaction was stopped by addition
of catalase to remove residual hydrogen peroxide. Under non-
reducing conditions untreated MPO ran as one single diffuse band
on SDS–PAGE at the expected molecular weight of the MPO
homodimer (146 kDa, Fig. 4B top panel, lane 1) consisting of two
identical glycosylated heavy chain monomers (58.5 kDa) and two
light chains (14.5 kDa). The heavy and light chains are connected
via their covalent linkages to the heme prosthetic group. The two
monomers are linked via one disulﬁde bridge to form the dimer.
On some gels a faint band of 14.5 kDa was also visible for untreated
MPO, indicating that a minor fraction of the light chain can detach
from the homodimer under non-reducing conditions (Fig. 4D top
panel, lane 1). After reaction with hydrogen peroxide the single
band progressively changed into a doublet with a concomitant in-
crease in the appearance of a 14.5 kDa band (Fig. 4B top panel,
lanes 2–6) for the light polypeptide chain. The 60 kDa band visible
in lanes 2–6 originated from the added catalase. A second identical
gel was blotted on a PVDF membrane and enhanced chemilumi-
nescence was used to detect the heme prosthetic group. The strong
signal for untreated MPO at 146 kDa (Fig. 4B lower panel, lane 1)
decreased over time when the enzyme was treated with hydrogen
peroxide (Fig. 4B lower panel, lane 2–6). No chemiluminescence
signals appeared at other molecular weights on the membrane
after treatment with hydrogen peroxide. These results suggest that
the heme was degraded by hydrogen peroxide while there were
relatively subtle changes to the protein involving detachment of
the light chain from the heme.
Under reducing SDS–PAGE conditions untreated MPO should
theoretically run as one polypeptide band of the molar mass of
73 kDa for the monomer consisting of one heavy and one light sub-
unit linked via the heme. Under reducing conditions we observed
two additional bands at molar masses of approximately 60 and
14 kDa, as shown in Fig. 4C top panel, lane 1. Taking the above re-
sults under non-reducing conditions into consideration, it was con-
cluded that the polypeptide chain at approx. 60 kDa was the heavyTable 1
Protective effect of a reducing substrate on the loss of absorbance in the ferric state (430 nm
7.4) was further investigated under the same conditions as in Fig. 3A–C, with either 200 lM
further spectral changes were observed is shown as D time (min).
H2O2 (lM) Without substrate 200 lM a
Loss A430 nm (%) Dt (min) Loss A430
60 6.2 ± 2.8 120 4.1 ± 1.5
250 19.9 ± 3.2 120 5.5 ± 1.3
1500 78.1 ± 1.3 60 18.1 ± 1.8chain and the 14 kDa band was the light chain. When MPO was
treated with hydrogen peroxide, the intensity of the 73 kDa band
of the MPO monomer decreased progressively over time (Fig. 4C,
lanes 2–6) with no additional bands appearing. The catalase that
was added to stop the reaction ran at the same molar mass as
the heavy polypeptide chain. An identical gel run under reducing
conditions was blotted onto a PVDF membrane and again the heme
prosthetic group was visualized using chemiluminescense. The
heme group of untreated MPO showed one strong signal at the
molecular weight of 73 kDa (Fig. 4C lower panel, lane 1), which
upon treatment with hydrogen peroxide progressively decreased
with no additional signals appearing on the blot (Fig. 4C lower pa-
nel, lanes 2–6).
MPO was also reacted with increasing hydrogen peroxide con-
centrations for two hours and subsequently resolved by SDS–PAGE
under non-reducing condition (Fig. 4D upper panel). The same
fragmentation pattern as described above in both the high and
low molar mass regions was observed with increasing concentra-
tions of hydrogen peroxide. The doublet became very apparent
from lane 6 (100:1 ratio of hydrogen peroxide to protein). At a ratio
of 2000:1 (lane 10) the most prominent high molecular weight
band was observed at approx. 120 kDa which correlated well with
the molecular weight of the homodimer that has lost both light
chains (117 kDa), whereas the second prominent high molecular
weight band correlated with the homodimer that has lost one light
chain (131.5 kDa). At the same time a strongly increased band for
the light chain at 14.5 kDa was observed. The 38 kDa fragment also
visible on this gel, was observed only on some of the gels run under
the same conditions and was interpreted earlier as a degradation
product deriving from a speciﬁc cleavage between Met243 (that
forms the sulfonium ion linkage at pyrrole ring A) and Pro244
[19]. The heme prosthetic group was detected again using chemi-
luminescence (Fig. 4D, lower panel). The intensity of the band de-
creased with increasing concentrations of hydrogen peroxide
which became very noticeable from lane 7 (167:1 ratio of hydrogen
peroxide to MPO) (Fig. 4D top panel, lanes 7–10). Collectively,
these results indicate that as MPO is inactivated by hydrogen per-
oxide the heme group is destroyed with concomitant release of
iron and the light chain becomes detachable from the homodimer
under SDS–PAGE conditions as a consequence of the heme
destruction.
Hydrogen peroxide-mediated changes to protein unfolding and the
thermal stability of MPO
Next we evaluated the impact of hydrogen peroxide treatment
on the thermal stability of MPO. With native MPO one single endo-
therm was obtained that was best ﬁtted by a non-two-state transi-
tion with maxima at 84.0 and 88.4 C which conﬁrms recently
published data [20]. Treatment of MPO with a 100-fold excess of
hydrogen peroxide resulted in a very similar unfolding pathway
(Tm1 = 83.9 and Tm2 = 86.5 C) for the protein (Fig. 5A). This also in-
cludes the calculated calorimetric enthalpies for the two transi-
tions (Table 2). With a 1000-fold excess of hydrogen peroxide
three transitions were seen with Tm1 = 75.0 C, Tm2 = 85.2 C and). The absorbance loss of the heme Soret peak (1.5 lM in 50 mM phosphate buffer, pH
ascorbate or 5 mM bromide plus 5 mM methionine present. The time until no more
scorbate 5 mM bromide
5 mM methionine
nm (%) Dt (min) Loss A430 nm (%) Dt (min)
0.7 9.6 ± 1.0 15
1 10.5 ± 1.6 40
2.5 20.7 ± 1.5 60
Fig. 4. Structural consequences of myeloperoxidase incubated with hydrogen peroxide. (A) Detection of iron release from the heme prosthetic group. 1.5 lM MPO was
reacted with 1.5 mM hydrogen peroxide in 50 mM sodium acetate buffer, pH 7.4, (column 2). Column 1 shows the result for untreated MPO. Ferrozine was used to measure
the release of iron from the heme group (n = 3). (B, C) SDS–PAGE: Time course of MPO reacted with hydrogen peroxide. Top panels: 1.5 lMMPO was reacted with 1.5 mM of
hydrogen peroxide in 50 mM phosphate buffer, pH 7.4, and 100 lM DTPA. 15 lL aliquots were taken at 5 min (lane 2), 10 min (lane 3), 25 min (lane 4), 45 min (lane 5) and
60 min (lane 6) and added to 20 lg/mL catalase to remove remaining hydrogen peroxide. Lane 1: negative control (15 lL of untreated MPO, no catalase added). The samples
were run on a 8–20% resolving SDS–PAGE under non-reducing (B) and reducing (C) conditions. Bottom panels: SDS–PAGE run under the same conditions as shown in top
panels, blotted onto a PVDF membrane and detection of the heme by chemiluminescence. (D) 1.5 lM MPO was incubated with hydrogen peroxide in 50 mM phosphate
buffer, pH 7.4, containing 100 lMDTPA for 2 h at various hydrogen peroxide to MPO ratios; 1:1 (lane 2), 5:1 (lane 3), 10:1 (lane 4), 40:1 (lane 5), 100:1 (lane 6), 167:1 (lane 7),
500:1 (lane 8), 1000:1 (lane 9) and 2000:1 (lane 10). 15 lL aliquots were taken and resolved on a 8–20% SDS PAGE under non-reducing conditions. Lane 1: negative control
(15 lL of untreated MPO). Bottom panel: SDS–PAGE run under the same conditions as shown in top panel, blotted onto a PVDF membrane and detection of the heme by
chemiluminescence.
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by SDS–PAGE analyses (compare with Fig. 4D, lane 9). In all assays
0.5 M GdnHCl was present to avoid non-speciﬁc aggregation dur-
ing heating, which is conﬁrmed by the fact that the sum of calori-
metric enthalpies (
P
Hm) were very similar for all ﬁtted transitions
(Table 2A) [20].
To gain more information about the hydrogen peroxide-medi-
ated structural changes, unfolding of MPO was also followed by
electronic circular dichroism (ECD) spectroscopy in the far-UV as
well as in the visible region. The far-UV ECD spectrum of MPO in
the native state exhibited two minima at 208 and 222 nm, respec-
tively (not shown) [20], which is typical for its mainly a-helical
structure [17,21,22]. Upon heating the protein from room temper-Table 2
(A) Calorimetric enthalpy calculated from thermal unfolding experiments (Fig. 5)
using differential scanning calorimetry. Conditions: 5 lM human myeloperoxidase in
5 mM phosphate buffer, pH 7.0. (Native enzyme or incubated with 100- or 1000-fold
stoichiometric amount of hydrogen peroxide for 2 h. (B) Thermodynamic data of
thermal unfolding (calculated from van’t Hoff plot) for MPO without and with 100
and 1000 fold excess of H2O2 followed by electronic circular dichroism spectroscopy
at 222 nm.
MPO MPO plus
100 eq H2O2
MPO plus
1000 eq H2O2
(A)
DHm (kJ mol1) – – 38.5
DHm2 (kJ mol1) 111.7 104.6 85.0
DHm3 (kJ mol1) 138.7 135.0 140.3P
DHm (kJ mol1) 250.5 239.6 263.8
MPO
([h]222)
MPO 100 eq H2O2
([h]222)
MPO 1000 eq H2O2
([h]222)
(B)
Tm (C) 76.8 ± 0.1 76.1 ± 0.2 73.2 ± 0.1
DHm (kJ mol-1) 261.4 ± 16.7 245.7 ± 18.9 266.7 ± 11.5
DSm (J mol-1) 746.8 ± 48.7 703.6 ± 54.3 770.1 ± 33.2
DCp (kJ mol-1 K-1) 4.88 4.70 5.41
DG25C (kJ mol-1) 18.9 17.4 17.6ature to 70 C a small fraction of ellipticity was already lost, but
melting of the a-helices started above 70 C (Tm = 76.8 C)
(Fig. 5C) concomitantly with the observed changes in the heme
cavity followed at 416 nm (i.e., minimum of Soret ellipticity)
(Fig. 5B). Thus unfolding of a-helices followed by ECD suggests a
cooperative two-state transition, including loss of the proper heme
environment. The conformational stability at room temperature
(DG25C) was calculated to be 18.9 kJ mol1 (222 nm) (Fig. 5C and
Table 2A). A similar unfolding pathway was seen when MPO was
incubated with a 100-fold stoichiometric excess of hydrogen per-
oxide. Upon incubation of MPO with a 1000-fold excess of hydro-
gen peroxide the loss of ellipticity in the initial phase was more
pronounced and the Tm-value of the main transition was lowered
to 73.2 C (Table 2B). From Fig. 5B it is also evident that incubation
of MPO with hydrogen peroxide leads to loss of Soret ellipticity
reﬂecting the loss of Soret absorbance at 430 nm (for comparison
see Fig. 3).Hydrogen peroxide-mediated modiﬁcations of amino acid residues of
MPO
When MPO was reacted with various hydrogen peroxide con-
centrations the loss of the heme prosthetic group was detectable
by following its absorbance at 430 nm but we could not identify
the modiﬁed heme products by mass spectrometry. Thus, we fo-
cused our attention on modiﬁcations of the protein by analyzing
tryptic peptides for oxidized sulfur containing amino acid residues.
10 out of 17 methionine residues were oxidized to methionine
sulfoxide (two from the light and eight from the heavy chain) as
depicted in Fig. 6A and summarized in Table 3. Oxidation of cys-
teine would not be detected because the sample was reduced
and alkylated before digestion. Of the modiﬁed methionines only
three were surface exposed (i.e., having more than 8 Å2 surface ex-
posed). Interestingly, many of the surface exposed methionines
were not modiﬁed (Fig. 6 and Table 3). This suggests that the
Fig. 5. Thermal stability and unfolding of humanmyeloperoxidase treated with hydrogen peroxide. (A) Thermal unfolding of leukocyte MPO followed by differential scanning
calorimetry. Normalized DSC scans of 5 lMMPO in 5 mM phosphate buffer, pH 7.4, after pre- and post-transitional baseline subtraction in the range of 20–100 C. Absence of
H2O2 (black line), incubation with 500 lM H2O2 (blue line) and incubation with 5 mM H2O2 (red line). Experimental data and ﬁtting to a non-two-state model (thin black
lines) are shown. (B) Thermal unfolding followed by circular dichroism at 416 nm. Same conditions as in (A). (C) Thermal unfolding of leukocyte MPO followed by circular
dichroism at 222 nm. The insets represent the corresponding van’t Hoff plots and linear ﬁts. Same conditions as in (A). (For interpretation of the references to color in this
ﬁgure legend, the reader is referred to the web version of this article.)
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but served as scavenger of protein radicals formed inside the pro-
tein. The methionine residue that forms the covalent sulfonium ion
linkage with the vinyl group on pyrrole ring A (Met243) was not
modiﬁed.Discussion
In this investigation we have shown that MPO is exquisitely
sensitive to a fast but limited inactivation event mediated by low
concentrations of hydrogen peroxide. Higher concentrations of
hydrogen peroxide protect against this fast inactivation event but
lead to a slower pathway of inactivation in which the heme pros-
thetic groups are destroyed, and in the process their iron is re-
leased and the small polypeptide subunits detach from the heme
prosthetic group.
Human myeloperoxidase is a cationic 146 kDa dimer of high
conformational and thermal stability [17,20,21,22] with a single
disulﬁde bridge between symmetry-related halves (73 kDa), each
of which contains two polypeptides of 14.5 and 58.5 kDa. The hea-
vy polypeptide is glycosylated and contains ﬁve intra-chain disul-
ﬁdes whereas the light polypeptide contains only one [21,22]. Eachsubunit of MPO contains a derivative of protoporphyrin IX in which
the methyl groups on pyrrole rings A and C are linked via ester
bonds to the carboxyl groups of highly conserved aspartate and
glutamate residues [21,22]. In addition, the b-carbon of the vinyl
group on pyrrole ring A forms a covalent bond with the sulfur atom
of a fully conserved methionine [20,21]. As a consequence, the
heme porphyrin ring is considerably distorted from planarity, con-
fering unique spectral and redox properties to MPO [23,24].
The mechanisms of inactivation of MPO by hydrogen peroxide
are understandable in terms of the protein’s architecture and the
redox transformations it undergoes during turnover (Fig. 7). Reac-
tion of hydrogen peroxide with ferric MPO leads to reductive het-
erolytic cleavage of its oxygen–oxygen bond and oxidation of the
enzyme to its Compound I state (Fig. 7; Reaction 1). This form of
MPO contains two oxidizing equivalents more than the resting en-
zyme [17]. Compound I contains an oxoiron (IV) and a p-cation
radical on the porphyrin ring. It has high one- and two-electron
reduction potentials [25–27], allowing the oxidation of numerous
one- and two-electron donors. Compound I is either reduced di-
rectly by (pseudo-)halides (X = Cl, Br, SCN) to the resting state
producing hypohalous acids (HOX = HOCl, HOBr, HOSCN) (Reaction
2) or it undergoes one-electron reduction by a typical peroxidase
substrate (AH, Reaction 3a) and hydrogen peroxide (Reaction 3b)
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ide (O2- or HO2), respectively [28]. Finally, Compound II is re-
duced back to the resting state with either another peroxidase
substrate (Reaction 4a) [29] or superoxide (Reaction 4b) [30]. Fur-
thermore, at high concentrations of hydrogen peroxide Compound
II can be converted to Compound III (Reaction 5) [31], where fer-
rous MPO with bound dioxygen exists in equilibrium with ferricFig. 6. Modiﬁcation of amino acids of myeloperoxidase incubated with hydrogen pero
methionine residues of MPO after treatment with hydrogen peroxide. Mature MPO is a h
heavy chain (467 amino acids, black). The small excised hexa-peptide between the light a
turquiose, amino acids involved in the covalent link with the prosthetic group are in gre
disulﬁde bridge between the subunits is marked by # and ligands of the calcium ion bind
protein with the ﬁrst cysteine in the small polypeptide designated as residue 1. Amino ac
residues are highlighted in red. (B) 3D structure of the MPO monomer (one light and
methionine residues which were detected by LC-MS/MS when 1.5 lM MPO was reacte
modiﬁed by H2O2 incubation are depicted in yellow, oxidized methionines are shown
references to color in this ﬁgure legend, the reader is referred to the web version of thiMPO with bound superoxide. Compound III slowly decays to ferric
MPO and superoxide. Alternatively, it can decay to ferrous MPO
which rapidly recombines with dioxygen or reacts with hydrogen
peroxide to form Compound II (Reaction 6) [31]. Based on burst
phase kinetics for hydrogen peroxide consumption by MPO in
the absence of chloride, it has also been proposed that the enzyme
has catalatic activity, degrading hydrogen peroxide to oxygen andxide. (A) LC-MS/MS analysis (amino acid sequence coverage of 86%) and oxidized
omodimer, each half being composed of a light chain (106 amino acids, blue) and a
nd heavy subunit is depicted in grey. Important catalytic residues are highlighted in
en. Glycosylation sites (asparagines, N) are marked by ⁄, the cysteine that forms the
ing site are underlined. The amino acid numbering for MPO is based on the mature
id sequence coverage by LC-MS/MS is depicted in bold letters, oxidized methionine
one heavy chain covalently linked via the heme group) showing the ten oxidized
d with 1.5 mM of hydrogen peroxide. Surface exposed methionines that were not
in red. For deﬁnition of surface accessibility see Table 4. (For interpretation of the
s article.)
Fig. 7. Proposed reaction scheme for redox interconversion of MPO in the presence of hydrogen peroxide. In the micromolar H2O2 concentration range cycling of MPO
includes the ferric state, Compound I and Compound II and Reactions 1, 3b and 4b (blue cycle). Compound II accumulates. The strong electrophilicity of Compound I oxidizes
the prosthetic group and the protein. Inactivation is suppressed in the presence of one- (Reactions 3a and 4a) and two-electron donors (Reaction 2). In the millimolar
concentration range Compound II conversion to Compound III (dark grey intermediates) becomes relevant and cycling of MPO then includes the ferric and ferrous state,
Compound I, Compound II and Compound III. The latter intermediate accumulates. Upon reaction of Compound III with excess of hydrogen peroxide reactive oxidants might
be formed that destroy the heme and oxidize the protein. (For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this
article.)
Table 3
LC-MS/MS analysis of oxidized tryptic peptides of MPO when reacted with hydrogen peroxide. 1.5 lMMPO was reacted with 1.5 mM of hydrogen peroxide in 50 mM phosphate
buffer pH 7.4. The reduced and alkylated protein was digested with trypsin and peptides were analyzed by LC-MS/MS. Peptides with a signal ratio of treatment versus control of
P3 and a p value of 60.001 are presented.
MPO amino acid # Identiﬁed modiﬁed peptide Oxidized residue on
peptide
Charge m/z
Value
Ratio P3 treatment vs
control
p-value
60.001
SD
M 85 M 87 SLmFmQWGQLLDHDLDFTPEPAAR M3
M5
3 950.7812 11.36 1.02E-5 2.75
M 287 KIVGAmVQIITYR M6 3 503.2933 19.68 1.08E-6 4.59
M 306 DYLPLVLGPTAmR M12 2 731.3934 6.72 5.99E-10 0.85
M 306 DYLPLVLGPTAmRK M12 2 795.4401 7.06 0.00016 1.41
M 306 KIVGAMVQIITYRDYLPLVLGPTAmRK M25 4 766.4382 4.30 1.72E-5 1.06
M 343 YGHTLIQPFmFR M10 2 763.3850 5.06 8.60E-6 0.42
M 343 YGHTLIQPFmFR M10 3 509.2593 10.82 3.43E-5 1.46
M 343 IANVFTNAFRYGHTLIQPFmFR M20 4 665.5958 9.76 1.85E-6 3.00
M 385 GLmATPAKLNR M3 2 594.3316 9.28 2.38E-5 0.57
M 385 VVLEGGIDPILRGLmATPAKLNR M15 3 817.1353 36.18 7.90E-6 6.39
M 411 LFEQVmRIGLDLPALNmQR M6
M17
3 759.4016 13.59 0.000266 2.42
M 422 IGLDLPALNmQR M10 2 678.8680 7.38 1.00E-5 0.53
M 465 M 478 LmEQYGTPNNIDIWmGGVSEPLKR M2
M15
3 927.4525 16.01 2.76E-5 4.14
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hydrogen peroxide also reduces Compound I directly in a two-elec-
tron reaction to produce dioxygen [32]. However, no evidence for
this reaction has been demonstrated using pre-steady-state kinetic
measurements [28,33]. All of these redox intermediates are rele-
vant to the physiological activities of MPO because when the en-
zyme is released by neutrophils into phagosomes or the
extracellular environment it reacts with both superoxide and
hydrogen peroxide [34,35].
It has been demonstrated that a ten-fold molar excess of hydro-
gen peroxide over MPO is needed [28] for complete conversion of
ferric MPO to Compound I, which is subsequently reduced to Com-
pound II via Reaction 3b. Among heme peroxidases MPO is unique
in catalyzing the one-electron oxidation of hydrogen peroxide to
superoxide [28]. Compound I is likely to be the crucial redox inter-mediate in the fast inactivation pathway because there was irre-
versible loss of peroxidase activity at ratios lower than 10:1.
Protection of the enzyme from this fast inactivation event by high
concentrations of hydrogen peroxide and reducing substrates,
including ascorbate and bromide, can be explained by their reac-
tions with Compound I. Compound I has a very positive reduction
potential [25,26] so that in the absence of exogenous electron do-
nors it will promote radical oxidation reactions within the heme
group or with the protein moiety.
At higher concentrations of hydrogen peroxide analysis of the
loss of peroxidase activity at a constant oxidant to protein ratio
conformed to the kinetics expected for mechanism-based inhibi-
tion [16]. The calculated partition ratio (r = 799), the inactivation
rate constant (kin = 3.9  103 s1) and the dissociation constant
for hydrogen peroxide (K0 = 740 lM) suggest that at higher concen-
Table 4
Surface exposure [37] of methionines in human myeloperoxidase. In addition, the distance of the Ca atom of the respectives methionines to the heme iron is given.
Methionine Molecular surface accessibility (Å2) Distance (Ca) to heme iron (Å)
Residue Oxidized Total Backbone Sidechain
13 no 17.8993 0.5285 17.3707 26.6
85 yes 0.0000 0.0000 0.0000 14.7
87 yes 1.0485 0.1747 0.8737 10.3
175 no 0.1747 0.0000 0.1747 14.7
190 no 36.5191 9.6475 26.8715 33.1
243 no 0.1747 0.0000 0.1747 10.8
249 no 0.8047 0.1057 0.6990 15.3
287 yes 1.3979 0.0000 1.3979 22.6
306 yes 10.8340 0.1747 10.6593 23.0
343 yes 0.0000 0.0000 0.0000 15.7
353 no 14.6223 0.3495 14.2728 26.9
385 yes 0.0000 0.0000 0.0000 20.0
411 yes 15.8951 5.1581 10.7370 17.1
422 yes 0.0000 0.0000 0.0000 12.3
465 yes 11.4057 2.8131 8.5926 26.1
478 yes 0.0000 0.0000 0.0000 14.2
522 no 48.8422 2.6605 46.1817 37.4
553 no 31.7514 0.9147 30.8367 21.1
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strate for MPO. A turnover of 799 + 1 molecules of hydrogen perox-
ide per MPO is followed by irreversible inactivation of the enzyme
under the conditions tested. Thus, the mechanism of inactivation
under these conditions appears to be different from that at low
concentrations of hydrogen peroxide.
Spectral analysis revealed that formation of Compound II was
associated with minimal inactivation and heme loss. In contrast,
there was extensive degradation of the heme groups and loss of
activity when the concentration of hydrogen peroxide was sufﬁ-
cient to convert the enzyme to Compound III (Reaction 5). Previous
work with lactoperoxidase suggested that its inactivation by
hydrogen peroxide resulted from reaction of the oxidant with
either Compound III or the ferrous enzyme to produce reactive
oxygen species including singlet oxygen and hydroxyl radical
[8,36]. The role of ferrous MPO is questionable since it rapidly
binds O2 or reacts with H2O2 forming Compound III or Compound
II, respectively. In any case, we found that ten of its methionine
residues were oxidized to methionine sulfoxide at high concentra-
tions of hydrogen peroxide. Most of the oxidized methionine resi-
dues are located in the interior of the protein whereas the majority
of the surface exposed methionine residues were not modiﬁed.
This result suggests that radical production within the protein
was responsible for oxidation of these residues as opposed to their
direct reaction of hydrogen peroxide. The protection afforded by
bromide and ascorbate can be explained by their ability to promote
rapid consumption of hydrogen peroxide via Reactions 3a and 4a
and prevent the conversion of Compound II to Compound III.
Although MPO has high thermal and conformational stability
[19], the oxidative modiﬁcation induced by hydrogen peroxide
were able to disrupt the proteins structural integrity. This was re-
ﬂected by loss of absorbance as well as ellipticity at the Soret max-
imum, which suggests that the heme was degraded. This was
conﬁrmed by demonstrating that high concentrations of hydrogen
peroxide promote the release of heme iron. Degradation of the
heme groups explains why the light polypeptide chains became
detached from the heme and subsequently from the protein under
SDS–PAGE conditions. These polypeptides are linked to the heme
groups via an ester bond with Asp94. Presumably this or an adja-
cent bond must break when the heme is degraded by hydrogen
peroxide. The free iron would also be expected to contribute to fur-
ther protein damage because it is likely to catalyze site speciﬁc
Fenton-type reactions with hydrogen peroxide.Conclusion
We have identiﬁed two mechanisms by which hydrogen perox-
ide can inactivate MPO. The ﬁrst involves formation of Compound I
at low concentrations of hydrogen peroxide where, in the absence
of a reducing substrate, the strong electrophilicity of this redox
intermediate enables it to oxidize the heme group or protein moi-
ety. Secondly, hydrogen peroxide is likely to react with Compound
III to give rise to reactive oxidants that destroy the heme and oxi-
dize the protein. Under normal physiological conditions, such that
reducing substrates are always present and the concentration of
hydrogen peroxide does not accumulate, these mechanisms of
inactivation are unlikely to occur in vivo. However, it is within
the conﬁnes of the neutrophil phagosomes where these mecha-
nisms of inactivation are most likely to operate. The concentration
of chloride inside phagosomes has been reported to be approxi-
mately 70 mM [38]. If this declines due to its oxidation to hypo-
chlorous acid and the conversion to chloramines [39], then
Compound I may be free to oxidize itself. Hydrogen peroxide
may also accumulate sufﬁciently to react with Compound III,
which is the predominant form of the enzyme in this compartment
[39]. Hypochlorous acid could also contribute to inactivation of
MPO within phagosomes after other more abundant targets are
quenched. These mechanisms would be reliant on continued activ-
ity of the NADPH oxidase which is also susceptible to inactivation
[40]. Inactivation via Compound I could be exploited in the search
for pharmacological inhibitors of MPO. Inhibitors that bind tightly
to the active site of MPO and prevent binding of reducing sub-
strates would make the enzyme susceptible to inactivation by
low concentrations of hydrogen peroxide.
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